Genomics care provider Genome Medical closed a $60m round backed by several corporates while brokerage software producer Alpaca secured $50m.

Funding

US-based genomics-focused healthcare provider Genome Medical has completed a $60m series C round featuring GV, Amgen Ventures, Kaiser Permanente Ventures and Illumina Ventures – on behalf of internet technology group Alphabet, pharmaceutical firm Amgen, healthcare provider Kaiser Permanente and genomic medicine producer Illumina – as well as Echo Health Ventures, which is backed by health services provider Cambia Health. The round was led by Casdin Capital and included Perceptive Advisors, Canaan Partners, LRVHealth, Revelation Partners, HealthInvest Equity Partners, Avestria…

Robert Lavine

Robert Lavine is special features editor for Global Venturing.